Anthony Hunt, Director at REPLIGEN CORP (RGEN), sold 44,382 shares at $145.95 ($6.5M) on 2024-09-10, disclosed to the SEC on 2024-09-12.
Scheduled sale ($6.5M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $143.77 | 1,495 | $215K | 3.3% |
| 2 | $143.77 | 1,495 | $215K | 3.3% |
| 3 | $144.88 | 9,369 | $1.4M | 21.0% |
| 4 | $144.88 | 9,369 | $1.4M | 21.0% |
| 5 | $145.95 | 10,723 | $1.6M | 24.3% |
| 6 | $145.95 | 10,723 |
| $1.6M |
| 24.3% |
| 7 | $146.67 | 604 | $89K | 1.4% |
| 8 | $146.67 | 604 | $89K | 1.4% |
| Total | $145.37 avg | 44,382 | $6.5M | 100% |
| Filing → |
| RGEN | SELL | 2025-09-11 | $7.0M | — | Filing → |
| RGEN | SELL | 2025-05-16 | $6.5M | — | Filing → |
| RGEN | SELL | 2025-03-19 | $8.1M | — | Filing → |